Cannabis-induced attenuated psychotic symptoms: implications for prognosis in young people at ultra-high risk for psychosis.
Identifieur interne : 001493 ( Main/Exploration ); précédent : 001492; suivant : 001494Cannabis-induced attenuated psychotic symptoms: implications for prognosis in young people at ultra-high risk for psychosis.
Auteurs : M J Mchugh [Australie] ; P D Mcgorry [Australie] ; A R Yung [Royaume-Uni] ; A. Lin [Australie] ; S J Wood [Australie] ; J A Hartmann [Australie] ; B. Nelson [Australie]Source :
- Psychological medicine [ 1469-8978 ] ; 2017.
Descripteurs français
- KwdFr :
- MESH :
- effets indésirables : Abus de marijuana, Cannabis.
- étiologie : Psychoses toxiques.
- Adolescent, Adulte, Femelle, Humains, Jeune adulte, Mâle, Pronostic, Risque, Études de suivi, Évolution de la maladie.
English descriptors
- KwdEn :
- MESH :
- adverse effects : Cannabis.
- complications : Marijuana Abuse.
- etiology : Psychoses, Substance-Induced.
- Adolescent, Adult, Disease Progression, Female, Follow-Up Studies, Humans, Male, Prognosis, Risk, Young Adult.
Abstract
BACKGROUND
Cannabis use shows a robust dose-dependent relationship with psychosis risk among the general population. Despite this, it has been difficult to link cannabis use with risk for transitioning to a psychotic disorder among individuals at ultra-high risk (UHR) for psychosis. The present study examined UHR transition risk as a function of cannabis use characteristics which vary substantially between individuals including age of first use, cannabis abuse severity and a history of cannabis-induced attenuated psychotic symptoms (APS).
METHOD
Participants were 190 UHR individuals (76 males) recruited at entry to treatment between 2000 and 2006. They completed a comprehensive baseline assessment including a survey of cannabis use characteristics during the period of heaviest use. Outcome was transition to a psychotic disorder, with mean time to follow-up of 5.0 years (range 2.4-8.7 years).
RESULTS
A history of cannabis abuse was reported in 58% of the sample. Of these, 26% reported a history of cannabis-induced APS. These individuals were 4.90 (95% confidence interval 1.93-12.44) times more likely to transition to a psychotic disorder (p = 0.001). Greater severity of cannabis abuse also predicted transition to psychosis (p = 0.036). However, this effect was mediated by higher abuse severity among individuals with a history of cannabis-induced APS.
CONCLUSIONS
Findings suggest that cannabis use poses risk in a subpopulation of UHR individuals who manifest cannabis-induced APS. Whether this reflects underlying genetic vulnerability requires further study. Nevertheless, findings reveal an important early marker of risk with potentially significant prognostic utility for UHR individuals.
DOI: 10.1017/S0033291716002671
PubMed: 27821204
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Cannabis-induced attenuated psychotic symptoms: implications for prognosis in young people at ultra-high risk for psychosis.</title><author><name sortKey="Mchugh, M J" sort="Mchugh, M J" uniqKey="Mchugh M" first="M J" last="Mchugh">M J Mchugh</name><affiliation wicri:level="1"><nlm:affiliation>Orygen,The National Centre for Excellence in Youth Mental Health,35 Poplar Road,Parkville,VIC 3052,Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Orygen,The National Centre for Excellence in Youth Mental Health,35 Poplar Road,Parkville,VIC 3052</wicri:regionArea><wicri:noRegion>VIC 3052</wicri:noRegion></affiliation></author><author><name sortKey="Mcgorry, P D" sort="Mcgorry, P D" uniqKey="Mcgorry P" first="P D" last="Mcgorry">P D Mcgorry</name><affiliation wicri:level="1"><nlm:affiliation>Orygen,The National Centre for Excellence in Youth Mental Health,35 Poplar Road,Parkville,VIC 3052,Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Orygen,The National Centre for Excellence in Youth Mental Health,35 Poplar Road,Parkville,VIC 3052</wicri:regionArea><wicri:noRegion>VIC 3052</wicri:noRegion></affiliation></author><author><name sortKey="Yung, A R" sort="Yung, A R" uniqKey="Yung A" first="A R" last="Yung">A R Yung</name><affiliation wicri:level="3"><nlm:affiliation>Institute of Brain, Behaviour and Mental Health,University of Manchester,Manchester,UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Institute of Brain, Behaviour and Mental Health,University of Manchester,Manchester</wicri:regionArea><placeName><settlement type="city">Manchester</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Manchester</region></placeName></affiliation></author><author><name sortKey="Lin, A" sort="Lin, A" uniqKey="Lin A" first="A" last="Lin">A. Lin</name><affiliation wicri:level="1"><nlm:affiliation>Telethon Kids Institute,University of Western Australia,WA 6008,Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Telethon Kids Institute,University of Western Australia,WA 6008</wicri:regionArea><wicri:noRegion>WA 6008</wicri:noRegion></affiliation></author><author><name sortKey="Wood, S J" sort="Wood, S J" uniqKey="Wood S" first="S J" last="Wood">S J Wood</name><affiliation wicri:level="1"><nlm:affiliation>Orygen,The National Centre for Excellence in Youth Mental Health,35 Poplar Road,Parkville,VIC 3052,Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Orygen,The National Centre for Excellence in Youth Mental Health,35 Poplar Road,Parkville,VIC 3052</wicri:regionArea><wicri:noRegion>VIC 3052</wicri:noRegion></affiliation></author><author><name sortKey="Hartmann, J A" sort="Hartmann, J A" uniqKey="Hartmann J" first="J A" last="Hartmann">J A Hartmann</name><affiliation wicri:level="1"><nlm:affiliation>Orygen,The National Centre for Excellence in Youth Mental Health,35 Poplar Road,Parkville,VIC 3052,Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Orygen,The National Centre for Excellence in Youth Mental Health,35 Poplar Road,Parkville,VIC 3052</wicri:regionArea><wicri:noRegion>VIC 3052</wicri:noRegion></affiliation></author><author><name sortKey="Nelson, B" sort="Nelson, B" uniqKey="Nelson B" first="B" last="Nelson">B. Nelson</name><affiliation wicri:level="1"><nlm:affiliation>Orygen,The National Centre for Excellence in Youth Mental Health,35 Poplar Road,Parkville,VIC 3052,Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Orygen,The National Centre for Excellence in Youth Mental Health,35 Poplar Road,Parkville,VIC 3052</wicri:regionArea><wicri:noRegion>VIC 3052</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2017">2017</date><idno type="RBID">pubmed:27821204</idno><idno type="pmid">27821204</idno><idno type="doi">10.1017/S0033291716002671</idno><idno type="wicri:Area/Main/Corpus">001563</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">001563</idno><idno type="wicri:Area/Main/Curation">001563</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">001563</idno><idno type="wicri:Area/Main/Exploration">001563</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Cannabis-induced attenuated psychotic symptoms: implications for prognosis in young people at ultra-high risk for psychosis.</title><author><name sortKey="Mchugh, M J" sort="Mchugh, M J" uniqKey="Mchugh M" first="M J" last="Mchugh">M J Mchugh</name><affiliation wicri:level="1"><nlm:affiliation>Orygen,The National Centre for Excellence in Youth Mental Health,35 Poplar Road,Parkville,VIC 3052,Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Orygen,The National Centre for Excellence in Youth Mental Health,35 Poplar Road,Parkville,VIC 3052</wicri:regionArea><wicri:noRegion>VIC 3052</wicri:noRegion></affiliation></author><author><name sortKey="Mcgorry, P D" sort="Mcgorry, P D" uniqKey="Mcgorry P" first="P D" last="Mcgorry">P D Mcgorry</name><affiliation wicri:level="1"><nlm:affiliation>Orygen,The National Centre for Excellence in Youth Mental Health,35 Poplar Road,Parkville,VIC 3052,Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Orygen,The National Centre for Excellence in Youth Mental Health,35 Poplar Road,Parkville,VIC 3052</wicri:regionArea><wicri:noRegion>VIC 3052</wicri:noRegion></affiliation></author><author><name sortKey="Yung, A R" sort="Yung, A R" uniqKey="Yung A" first="A R" last="Yung">A R Yung</name><affiliation wicri:level="3"><nlm:affiliation>Institute of Brain, Behaviour and Mental Health,University of Manchester,Manchester,UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Institute of Brain, Behaviour and Mental Health,University of Manchester,Manchester</wicri:regionArea><placeName><settlement type="city">Manchester</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Manchester</region></placeName></affiliation></author><author><name sortKey="Lin, A" sort="Lin, A" uniqKey="Lin A" first="A" last="Lin">A. Lin</name><affiliation wicri:level="1"><nlm:affiliation>Telethon Kids Institute,University of Western Australia,WA 6008,Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Telethon Kids Institute,University of Western Australia,WA 6008</wicri:regionArea><wicri:noRegion>WA 6008</wicri:noRegion></affiliation></author><author><name sortKey="Wood, S J" sort="Wood, S J" uniqKey="Wood S" first="S J" last="Wood">S J Wood</name><affiliation wicri:level="1"><nlm:affiliation>Orygen,The National Centre for Excellence in Youth Mental Health,35 Poplar Road,Parkville,VIC 3052,Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Orygen,The National Centre for Excellence in Youth Mental Health,35 Poplar Road,Parkville,VIC 3052</wicri:regionArea><wicri:noRegion>VIC 3052</wicri:noRegion></affiliation></author><author><name sortKey="Hartmann, J A" sort="Hartmann, J A" uniqKey="Hartmann J" first="J A" last="Hartmann">J A Hartmann</name><affiliation wicri:level="1"><nlm:affiliation>Orygen,The National Centre for Excellence in Youth Mental Health,35 Poplar Road,Parkville,VIC 3052,Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Orygen,The National Centre for Excellence in Youth Mental Health,35 Poplar Road,Parkville,VIC 3052</wicri:regionArea><wicri:noRegion>VIC 3052</wicri:noRegion></affiliation></author><author><name sortKey="Nelson, B" sort="Nelson, B" uniqKey="Nelson B" first="B" last="Nelson">B. Nelson</name><affiliation wicri:level="1"><nlm:affiliation>Orygen,The National Centre for Excellence in Youth Mental Health,35 Poplar Road,Parkville,VIC 3052,Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Orygen,The National Centre for Excellence in Youth Mental Health,35 Poplar Road,Parkville,VIC 3052</wicri:regionArea><wicri:noRegion>VIC 3052</wicri:noRegion></affiliation></author></analytic><series><title level="j">Psychological medicine</title><idno type="eISSN">1469-8978</idno><imprint><date when="2017" type="published">2017</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent (MeSH)</term><term>Adult (MeSH)</term><term>Cannabis (adverse effects)</term><term>Disease Progression (MeSH)</term><term>Female (MeSH)</term><term>Follow-Up Studies (MeSH)</term><term>Humans (MeSH)</term><term>Male (MeSH)</term><term>Marijuana Abuse (complications)</term><term>Prognosis (MeSH)</term><term>Psychoses, Substance-Induced (etiology)</term><term>Risk (MeSH)</term><term>Young Adult (MeSH)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Abus de marijuana (complications)</term><term>Adolescent (MeSH)</term><term>Adulte (MeSH)</term><term>Cannabis (effets indésirables)</term><term>Femelle (MeSH)</term><term>Humains (MeSH)</term><term>Jeune adulte (MeSH)</term><term>Mâle (MeSH)</term><term>Pronostic (MeSH)</term><term>Psychoses toxiques (étiologie)</term><term>Risque (MeSH)</term><term>Études de suivi (MeSH)</term><term>Évolution de la maladie (MeSH)</term></keywords><keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Cannabis</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Marijuana Abuse</term></keywords><keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Abus de marijuana</term><term>Cannabis</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Psychoses, Substance-Induced</term></keywords><keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Psychoses toxiques</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Disease Progression</term><term>Female</term><term>Follow-Up Studies</term><term>Humans</term><term>Male</term><term>Prognosis</term><term>Risk</term><term>Young Adult</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adolescent</term><term>Adulte</term><term>Femelle</term><term>Humains</term><term>Jeune adulte</term><term>Mâle</term><term>Pronostic</term><term>Risque</term><term>Études de suivi</term><term>Évolution de la maladie</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p><b>BACKGROUND</b></p><p>Cannabis use shows a robust dose-dependent relationship with psychosis risk among the general population. Despite this, it has been difficult to link cannabis use with risk for transitioning to a psychotic disorder among individuals at ultra-high risk (UHR) for psychosis. The present study examined UHR transition risk as a function of cannabis use characteristics which vary substantially between individuals including age of first use, cannabis abuse severity and a history of cannabis-induced attenuated psychotic symptoms (APS).</p></div><div type="abstract" xml:lang="en"><p><b>METHOD</b></p><p>Participants were 190 UHR individuals (76 males) recruited at entry to treatment between 2000 and 2006. They completed a comprehensive baseline assessment including a survey of cannabis use characteristics during the period of heaviest use. Outcome was transition to a psychotic disorder, with mean time to follow-up of 5.0 years (range 2.4-8.7 years).</p></div><div type="abstract" xml:lang="en"><p><b>RESULTS</b></p><p>A history of cannabis abuse was reported in 58% of the sample. Of these, 26% reported a history of cannabis-induced APS. These individuals were 4.90 (95% confidence interval 1.93-12.44) times more likely to transition to a psychotic disorder (p = 0.001). Greater severity of cannabis abuse also predicted transition to psychosis (p = 0.036). However, this effect was mediated by higher abuse severity among individuals with a history of cannabis-induced APS.</p></div><div type="abstract" xml:lang="en"><p><b>CONCLUSIONS</b></p><p>Findings suggest that cannabis use poses risk in a subpopulation of UHR individuals who manifest cannabis-induced APS. Whether this reflects underlying genetic vulnerability requires further study. Nevertheless, findings reveal an important early marker of risk with potentially significant prognostic utility for UHR individuals.</p></div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">27821204</PMID><DateCompleted><Year>2017</Year><Month>11</Month><Day>28</Day></DateCompleted><DateRevised><Year>2017</Year><Month>11</Month><Day>28</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1469-8978</ISSN><JournalIssue CitedMedium="Internet"><Volume>47</Volume><Issue>4</Issue><PubDate><Year>2017</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Psychological medicine</Title><ISOAbbreviation>Psychol Med</ISOAbbreviation></Journal><ArticleTitle>Cannabis-induced attenuated psychotic symptoms: implications for prognosis in young people at ultra-high risk for psychosis.</ArticleTitle><Pagination><MedlinePgn>616-626</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1017/S0033291716002671</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Cannabis use shows a robust dose-dependent relationship with psychosis risk among the general population. Despite this, it has been difficult to link cannabis use with risk for transitioning to a psychotic disorder among individuals at ultra-high risk (UHR) for psychosis. The present study examined UHR transition risk as a function of cannabis use characteristics which vary substantially between individuals including age of first use, cannabis abuse severity and a history of cannabis-induced attenuated psychotic symptoms (APS).</AbstractText><AbstractText Label="METHOD" NlmCategory="METHODS">Participants were 190 UHR individuals (76 males) recruited at entry to treatment between 2000 and 2006. They completed a comprehensive baseline assessment including a survey of cannabis use characteristics during the period of heaviest use. Outcome was transition to a psychotic disorder, with mean time to follow-up of 5.0 years (range 2.4-8.7 years).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A history of cannabis abuse was reported in 58% of the sample. Of these, 26% reported a history of cannabis-induced APS. These individuals were 4.90 (95% confidence interval 1.93-12.44) times more likely to transition to a psychotic disorder (p = 0.001). Greater severity of cannabis abuse also predicted transition to psychosis (p = 0.036). However, this effect was mediated by higher abuse severity among individuals with a history of cannabis-induced APS.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Findings suggest that cannabis use poses risk in a subpopulation of UHR individuals who manifest cannabis-induced APS. Whether this reflects underlying genetic vulnerability requires further study. Nevertheless, findings reveal an important early marker of risk with potentially significant prognostic utility for UHR individuals.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>McHugh</LastName><ForeName>M J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Orygen,The National Centre for Excellence in Youth Mental Health,35 Poplar Road,Parkville,VIC 3052,Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McGorry</LastName><ForeName>P D</ForeName><Initials>PD</Initials><AffiliationInfo><Affiliation>Orygen,The National Centre for Excellence in Youth Mental Health,35 Poplar Road,Parkville,VIC 3052,Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yung</LastName><ForeName>A R</ForeName><Initials>AR</Initials><AffiliationInfo><Affiliation>Institute of Brain, Behaviour and Mental Health,University of Manchester,Manchester,UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Telethon Kids Institute,University of Western Australia,WA 6008,Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wood</LastName><ForeName>S J</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>Orygen,The National Centre for Excellence in Youth Mental Health,35 Poplar Road,Parkville,VIC 3052,Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hartmann</LastName><ForeName>J A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Orygen,The National Centre for Excellence in Youth Mental Health,35 Poplar Road,Parkville,VIC 3052,Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nelson</LastName><ForeName>B</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Orygen,The National Centre for Excellence in Youth Mental Health,35 Poplar Road,Parkville,VIC 3052,Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>11</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Psychol Med</MedlineTA><NlmUniqueID>1254142</NlmUniqueID><ISSNLinking>0033-2917</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002188" MajorTopicYN="N">Cannabis</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="Y">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002189" MajorTopicYN="N">Marijuana Abuse</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011605" MajorTopicYN="N">Psychoses, Substance-Induced</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012306" MajorTopicYN="N">Risk</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cannabis</Keyword><Keyword MajorTopicYN="N">psychosis</Keyword><Keyword MajorTopicYN="N">ultra-high risk</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>11</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>11</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>11</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27821204</ArticleId><ArticleId IdType="pii">S0033291716002671</ArticleId><ArticleId IdType="doi">10.1017/S0033291716002671</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Australie</li><li>Royaume-Uni</li></country><region><li>Angleterre</li><li>Grand Manchester</li></region><settlement><li>Manchester</li></settlement></list><tree><country name="Australie"><noRegion><name sortKey="Mchugh, M J" sort="Mchugh, M J" uniqKey="Mchugh M" first="M J" last="Mchugh">M J Mchugh</name></noRegion><name sortKey="Hartmann, J A" sort="Hartmann, J A" uniqKey="Hartmann J" first="J A" last="Hartmann">J A Hartmann</name><name sortKey="Lin, A" sort="Lin, A" uniqKey="Lin A" first="A" last="Lin">A. Lin</name><name sortKey="Mcgorry, P D" sort="Mcgorry, P D" uniqKey="Mcgorry P" first="P D" last="Mcgorry">P D Mcgorry</name><name sortKey="Nelson, B" sort="Nelson, B" uniqKey="Nelson B" first="B" last="Nelson">B. Nelson</name><name sortKey="Wood, S J" sort="Wood, S J" uniqKey="Wood S" first="S J" last="Wood">S J Wood</name></country><country name="Royaume-Uni"><region name="Angleterre"><name sortKey="Yung, A R" sort="Yung, A R" uniqKey="Yung A" first="A R" last="Yung">A R Yung</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Bois/explor/PoplarV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001493 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001493 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Bois
|area= PoplarV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:27821204
|texte= Cannabis-induced attenuated psychotic symptoms: implications for prognosis in young people at ultra-high risk for psychosis.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:27821204" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a PoplarV1
| This area was generated with Dilib version V0.6.37. |  |